Pulmonx Corp (LUNG) › Shareholders' EquityPulmonx Corp (LUNG) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$149.39M2018: -$167.33M2019: -$187.38M2020: $226.13M2021: $193.24M2022: $154.01M2023: $118.31M2024: $85.81M2025: $54.12M$54.12M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$54.12M-36.9%2024$85.81M-27.5%2023$118.31M-23.2%2022$154.01M-20.3%2021$193.24M-14.5%2020$226.13M+220.7%2019-$187.38M-12.0%2018-$167.33M-12.0%2017-$149.39M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share